Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in…
Mirum Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application No. 16/994,368. The…
Read More...
Read More...
